Articles from Patterson Companies, Inc.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025.

Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities. The “go-shop” period expired at 11:59 p.m. (Central Time) on January 19, 2025.

Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price (VWAP) ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives), or a transaction value of approximately $4.1 billion, including the refinancing of Patterson’s receivables facilities.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 second quarter ended October 26, 2024.

Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health’s network of more than 1,000 supported practices nationwide.

Patterson Companies, Inc. (Nasdaq: PDCO) a leading distribution company in the dental and animal health industries, today announced that it has signed two separate acquisition agreements for its Animal Health business – Infusion Concepts in the United Kingdom and Mountain Vet Supply in the United States.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 first quarter ended July 27, 2024.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 fourth quarter ended April 27, 2024.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 third quarter ended January 27, 2024.

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024. Ms. Tomczik currently serves as Senior Vice President, Treasurer and Corporate Development of Target Corporation, a general merchandise retailer with stores in all 50 states and the District of Columbia. Ms. Tomczik will serve on the Board’s Audit and Finance Committee.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.6 billion (see attached Sales Summary for further details) in its fiscal 2024 first quarter ended July 29, 2023, an increase of 3.5 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 2.8 percent over the prior year period.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.72 billion (see attached Sales Summary for further details) in its fiscal fourth quarter ended April 29, 2023, an increase of 5.0 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 5.7 percent over the prior year period.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.60 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 28, 2023, an increase of 0.3 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 1.8 percent over the prior year period.

Patterson Companies, Inc. (Nasdaq: PDCO) today announced enhancements to its executive leadership team to further support the execution of its strategy. Kevin Barry, most recently the Company’s Interim Chief Financial Officer, has been named Chief Financial Officer, and Kevin Pohlman, most recently President of Patterson Animal Health, has been named Chief Operating Officer.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.63 billion (see attached Sales Summary for further details) in its fiscal second quarter ended October 29, 2022, a decrease of 1.4 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation, increased 0.7 percent over the prior year period.

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that its Board of Directors has appointed Don Zurbay, most recently Chief Financial Officer, as President and Chief Executive Officer. Mr. Zurbay succeeds Mark Walchirk who resigned following the Board’s investigation and determination that he violated company policy and demonstrated poor judgment regarding an encounter with an employee. The conduct did not relate to the company’s operations or the integrity of the company’s financial statements. Mr. Zurbay has also been elected to the Board. Kevin Barry, currently Vice President, Finance & Corporate Controller, has been appointed Interim Chief Financial Officer.

On September 13, 2022, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, November 4, 2022, to shareholders of record as of the close of business on October 21, 2022.

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that the Company will participate in the Piper Sandler Virtual Dental Investor Day on Tuesday, March 29, 2022 at 2:00 pm ET.

Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Philip McKoy has been elected to the Patterson Companies Board of Directors, effective December 13, 2021. Mr. McKoy currently serves as Chief Information Officer of Optum, the health technology and services business of UnitedHealth Group. Mr. McKoy will serve on the Board’s Audit Committee.

Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO) today announced leadership changes designed to help accelerate the company’s growth in the dental market, effective July 19, 2021.